Time to Say Goodbye: Handling an Executive’s Severance

Executives will terminate employment, like any other employee, but compensation and benefits issues to consider in connection with the termination of executive-level employees often require more work from Human Resources in managing the terms of the termination and subsequent payouts. This practice note discusses considerations for a smooth good-bye.

Read now »

Related Content

• Executive Separation Agreement Negotiation (Pro-employer)
  Hear advice on how you can help an employer protect its interests when negotiating separation agreements with executive employees. Often employers believe they owe executives few additional benefits after employment ends. If they choose to offer any severance, employers may offer just enough to make it difficult for the executive to turn down the offer. Prepare for a broader demand.

• Separation Agreements: Drafting and Negotiation Tips (Pro-Employer)
  Learn more about drafting a separation agreement and the common terms that you should consider including in them.

Practical Guidance Updates
Featuring the latest updates from your Practical Guidance account.   

• Employee Benefits & Executive Compensation Key Legal Developments Tracker
  Stay informed on new developments.
  • Retirement Plans. IRS announces that on or after February 28, 2023, it intends to issue opinion letters for pre-approved defined benefit plans that were (1) restated for changes in plan qualification requirements listed in the 2020 Cumulative List (see Notice 2020-14), and (2) filed with the IRS for the third six-year remedial amendment cycle under Rev. Proc. 2016-37 (which opened on August 1, 2020 and ended July 31, 2021). Announcement 2023-6.
  • Health and Welfare Plans. HHS releases initial guidance for the Medicare Prescription Drug Inflation Rebate Program under the Inflation Reduction Act providing that drug companies will rebate Medicare when their prescription drug prices increase faster than the rate of inflation for certain drugs dispensed to Medicare enrollees. HHS Press Release (Feb. 9, 2023).
  • Health and Welfare Plans. FTC imposes a fine of $1.5 million against GoodRx for the unauthorized disclosure of consumer health data. FTC Press Release (Feb. 1, 2023).
• Document alerts allow you to stay current on legal developments that affect your practice. Find out how to set up your document alerts.
• The Practical Guidance Journal Climate Change Special Edition features guidance on insuring for climate change, renewable energy initiatives, and a guide for public and private projects related to sea level rise.
• Legal Developments provide the latest updates and analyses of emerging topics impacting your practice area. Visit the Legal Developments page to see the latest topics, which also include breaking legal news and related Practical Guidance content. 
• Listen Up! The Practical Guidance and Law360 Podcasts Resource Kit features interviews with industry-leading attorneys on cutting edge issues in the law: NFTs, Cannabis, COVID-19, and more.
• Check out the new Practical Guidance Author Center! Learn about the 1750+ leading attorney authors contributing to our 22 practice areas and find out how you can Become a Practical Guidance Author. 
• New and Updated Practical Guidance Content
  • Adjusted DOL Penalties for Violations of Select ERISA Requirements Chart
  • SECURE 2.0 Act Tracker
  • Top Hat Plans
  • How Plan Sponsors Can Prepare for End of COVID Emergency Declarations
  • Provisions of SECURE 2.0 Act Applicable to Defined Benefits and Money Purchase Pension Plans
  • KPMG Report: Year-in-Review List of U.S. Federal Tax Developments for 2022
  • FTC Noncompete Ban Could Open State Litigation Floodgate
  • Fast-Approaching Deadlines for ACA Reporting and Similar State Reporting
  • Evolving Laws and Litigation Post-Dobbs: The State of Reproductive Rights as of January 2023

Experience results today with practical guidance, legal research, and data-driven insights—all in one place.

Experience Lexis+